179 related articles for article (PubMed ID: 36845683)
21. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
22. Cause-specific long-term mortality in survivors of childhood cancer in Switzerland: A population-based study.
Schindler M; Spycher BD; Ammann RA; Ansari M; Michel G; Kuehni CE;
Int J Cancer; 2016 Jul; 139(2):322-33. PubMed ID: 26950898
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.
Lin CH; Kuo KT; Chuang SS; Kuo SH; Chang JH; Chang KC; Hsu HC; Tien HF; Cheng AL
Clin Cancer Res; 2006 Feb; 12(4):1152-6. PubMed ID: 16489068
[TBL] [Abstract][Full Text] [Related]
26. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
28. Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
Schmitt AM; Herbrand AK; Fox CP; Bakunina K; Bromberg JEC; Cwynarski K; Doorduijn JK; Ferreri AJM; Illerhaus G; Issa S; Schorb E; Zucca E; Hemkens LG; Schandelmaier S; Kasenda B
Hematol Oncol; 2019 Dec; 37(5):548-557. PubMed ID: 31418878
[TBL] [Abstract][Full Text] [Related]
29. All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis.
Furst T; Hoffman H; Chin LS
J Neurosurg Sci; 2024 Feb; 68(1):44-50. PubMed ID: 31601065
[TBL] [Abstract][Full Text] [Related]
30. Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.
Song MK; Chung JS; Joo YD; Lee SM; Oh SY; Shin DH; Yun EY; Kim SG; Seol YM; Shin HJ; Choi YJ; Cho GJ
J Neurooncol; 2011 Sep; 104(3):825-31. PubMed ID: 21380743
[TBL] [Abstract][Full Text] [Related]
31. Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.
Dandachi D; Ostrom QT; Chong I; Serpa JA; Giordano TP; Kruchko C; Barnholtz-Sloan JS; Fowler N; Colen RR; Morón FE
Cancer Causes Control; 2019 May; 30(5):477-488. PubMed ID: 30888569
[TBL] [Abstract][Full Text] [Related]
32. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
[TBL] [Abstract][Full Text] [Related]
33. TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Munch-Petersen HD; Asmar F; Dimopoulos K; Areškevičiūtė A; Brown P; Girkov MS; Pedersen A; Sjö LD; Heegaard S; Broholm H; Kristensen LS; Ralfkiaer E; Grønbæk K
Acta Neuropathol Commun; 2016 Apr; 4():40. PubMed ID: 27101868
[TBL] [Abstract][Full Text] [Related]
34. Long-term cause-specific mortality among five-year survivors of childhood cancer.
Cardous-Ubbink MC; Heinen RC; Langeveld NE; Bakker PJ; Voûte PA; Caron HN; van Leeuwen FE
Pediatr Blood Cancer; 2004 Jun; 42(7):563-73. PubMed ID: 15127410
[TBL] [Abstract][Full Text] [Related]
35. Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study.
Tang D; Chen Y; Shi Y; Tao H; Tao S; Zhang Q; Ding B; He Z; Yu L; Wang C
Front Oncol; 2022; 12():817043. PubMed ID: 35223498
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of the tumor immune microenvironment and immune checkpoint pathway in primary central nervous system diffuse large B-cell lymphoma in the North Indian population.
Parkhi M; Chatterjee D; Bal A; Vias P; Yadav BS; Prakash G; Gupta SK; Radotra BD
APMIS; 2022 Feb; 130(2):82-94. PubMed ID: 34862664
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
Uldrick TS; Pipkin S; Scheer S; Hessol NA
AIDS; 2014 Jan; 28(3):397-405. PubMed ID: 24076659
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Cardiovascular Mortality among 80,042 Older Patients with Bladder Cancer.
Guan T; Su M; Luo Z; Peng W; Zhou R; Lu Z; Feng M; Li W; Teng Y; Jiang Y; Ou C; Chen M
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230496
[TBL] [Abstract][Full Text] [Related]
39. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
[TBL] [Abstract][Full Text] [Related]
40. Non-Cancer Causes of Death in Patients With Pancreatic Adenocarcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Based Study.
Harvitkar RU; Peri H; Zallipalli SN; Joseph SJ; Gattupalli GB; Ansari K
Cureus; 2021 Dec; 13(12):e20289. PubMed ID: 34926091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]